The same day that Gilde Healthcare announced its largest raise ever, fellow European VC Forbion did the same, indicating that the extended bear market has not dissuaded LPs from investing in top-tier firms. Forbion said Wednesday that it raised €1.35 billion ($1.5 billion) for its two newest funds, bringing the total raised across the two funds to €3 billion. Both Forbion Ventures Fund VI and Forbion Growth Opportunities Fund II have reach their hard-cap amounts, at €750 million and €600 million, respectively.
Supreme Court Justice Samuel Alito extended the hold on implementation of a Texas district court’s decision to overturn FDA’s approval of the abortion drug mifepristone. The court did not provide an explanation for the decision to extend the hold, originally set to expire at midnight Wednesday, to midnight of April 21. The case has broad implications for FDA and the biopharmaceutical industry...